A survey of aflatoxins in sesame seeds imported into Khorasan Province, Iran.

Sesame seed is one of the main nutrient substances which is used in the food industries of Khorasan Razavi, Iran. Because it is likely that stored sesame seeds are contaminated with mycotoxins, the levels of aflatoxins (AF) in five lots of imported sesame seeds before their distribution to the market were studied during one year. A total of 269 sub-samples were obtained from a total of 9,321 tons of sesame seeds from five importing companies. Aflatoxins at >1 µg/kg were found in 50 % of all samples, but at low levels in most cases, which is illustrated by mean AFB1 and total AF levels of 1.25 ± 3.70 and 1.43 ± 4.38 µg/kg, respectively. A few (1.9 %) samples exceeded the National Iranian Standard maximum accepted level for AFB1 (5 µg/kg) or total AF (15 µg/kg); the maximum total AF level found in one sample was 48 µg/kg. The results indicate that the risk of a violative AF contamination in imported sesame seeds is not negligible but is currently relatively low.

"Silymarin", a promising pharmacological agent for treatment of diseases.

Widespread use of herbal drugs because of their protective effects on different organs toxicity has been shown in many studies. These protective effects have been illustrated in the fields of nephrotoxicity, hepatotoxicity, viral hepatitis, cancer, in vitro fertilization, neurotoxicity, depression, lung diseases, prostate diseases etc. Silymarin has cytoprotection activities due to its antioxidant activity and radical scavenging. The possible known mechanisms of action of silymarin protection are blockade and adjustment of cell transporters, p-glycoprotein, estrogenic and nuclear receptors. Moreover, silymarin anti-inflammatory effects through reduction of TNF-α, protective effects on erythrocyte lysis and cisplatin-induced acute nephrotoxicity have been indicated in some studies. Silymarin has also inhibited apoptosis and follicular development in patients undergoing IVF. Basis on such data, silymarin can be served as a novel medication in complementary medicine.